Greece - Business Enterprise Expenditure on R&D Performed in the Pharmaceutical Industry
Since 2014, Greece Business Enterprise Expenditure on R&D Performed in the Pharmaceutical Industry rose 0.1% year on year. With $83,431,205.22 Million PPP in 2019, the country was number 27 among other countries in Business Enterprise Expenditure on R&D Performed in the Pharmaceutical Industry. Greece is overtaken by Czech Republic, which was number 26 at $108,981,820.05 Million PPP and is followed by Norway at $36,963,598.93 Million PPP. United States lead the ranking with $70,565,318,932.39 Million PPP in 2019, that is a growth of 3.3% compared to 2018. China, Japan and Germany respectively ranked number 2, 3 and 4 in this ranking. Iceland witnessed the best average annual growth at +43.9% per year, while Lithuania witnessed the worst performance at -42.6% per year.
Loading...
| Date | Million US Dollars PPP |
|---|---|
| 2019 | 83,431,205.22 |
| 2018 | 83,364,124.33 |
| 2017 | 87,976,316.11 |
| 2016 | 73,670,319.61 |
| 2015 | 69,304,517.36 |
How does Greece rank in Business Enterprise Expenditure on R&D Performed in the Pharmaceutical Industry?
| # | 69 Countries | Million US Dollars PPP | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
United States
|
70,565,318,932.39 | 2019 | +3.3 % | +4.5 % | View data | |
| 2 |
#2
China
|
13,956,388,273.35 | 2019 | +4.5 % | +6.1 % | View data | |
| 26 |
#26
Czech Republic
|
108,981,820.05 | 2019 | -1.9 % | +5.2 % | View data | |
| 27 |
#27
Greece
|
83,431,205.22 | 2019 | +0.1 % | +0.1 % | View data | |
| 28 |
#28
Norway
|
36,963,598.93 | 2019 | -2.1 % | +0.1 % | View data | |